Methods of Placental Delivery and the Amount of Blood Loss During Cesarean Section

May 24, 2017 updated by: ahmed abdulmoneim altraigey, Benha University

How Can Methods of Placental Delivery Affect the Amount of Blood Loss During Cesarean Section?

To compare between the effect of controlled cord traction and manual removal of the placenta on blood loss among women undergoing caesarean sections

Study Overview

Detailed Description

Cesarean section (CS) is one of the most commonly performed major abdominal operations in women worldwide and its rate is increasing dramatically every year.

Some of the reported short-term morbidities include hemorrhage, postoperative fever and endometritis. The method of delivering the placenta is one procedure that may contribute to an increase or decrease in the morbidity of CS.

On an average 0.5-1 liter of blood is lost during CS, many variable techniques have been tried to reduce this blood loss. Such techniques include finger splitting versus scissor cutting of incision, in situ stitching verses exteriorization and stitching of uterus , and finally spontaneous or manual removal of the placenta.

Two common methods used to deliver the placenta at CS are cord traction and manual removal.

Manual removal of the placenta which the obstetrician introduce his hand into the uterine cavity to cleave the placenta from the decidua basalis as soon as possible after the delivery of the infant and controlled cord traction in which the obstetrician do external uterine massage and gentle traction on the exposed umbilical cord to facilitate placental delivery.

Opinions differ about the best for placental delivery technique at CS. Some trials showed a reduced risk of blood loss with controlled cord traction (3) and others showed that manual removal of placenta at CS do not increase perioperative blood loss.

Authors concluded that manual delivery of the placenta was significantly associated with greater operative blood loss and greater decrease in postoperative hemoglobin levels and postpartum maternal infectious morbidity but with shorter operative time compared with spontaneous placental separation .

In addition, it is known that the blood loss at CS delivery is difficult to estimate, and numerous different methods including serial change in hematocrit (Hct), hemoglobin (Hb) level, visual estimation and the gravimetric method are described.

A low, but significant, correlation was found between visually estimated blood loss and perioperative hemoglobin change in women delivering by CS. However, hemoglobin , hematocrit levels and visual estimation are the most commonly used technique for estimating blood loss at delivery.

Study Type

Interventional

Enrollment (Actual)

288

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Asir,
      • Khamis Mushait,, Asir,, Saudi Arabia, 101
        • Postpartum ward of Armed Forces Hospital, Southern Region

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

- All informed and consented women undergoing elective or emergency CS will be legible for enrollment into the study

Exclusion Criteria:

  • Multiple gestation.
  • Pregnancy below 34 weeks.
  • Severe maternal anemia.
  • Severe pre-eclampsia
  • Prolonged labor.
  • Prolonged rupture of the membranes with fever.
  • Placental abruption.
  • Placenta previa.
  • Placenta accreta.
  • Clotting disorders.
  • Current or previous history of a significant disease including heart disease, liver, renal disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: manual removal group
Group will be assigned for manual removal of the placenta as the surgeon will introduce his hand into the uterine cavity to cleave the placenta from the decidua basalis as soon as possible after the delivery of the baby by caesarean section
one of the standard procedures for placental delivery during caesarean section the surgeon will introduce his hand into the uterine cavity to cleave the placenta from the decidua basalis as soon as possible after the delivery of the baby
Experimental: cord traction group
Group will be assigned for controlled cord traction as the surgeon do external uterine massage and gentle traction on the exposed umbilical cord to facilitate placental delivery after the delivery of the baby by caesarean section
one of the standard procedures for placental delivery during caesarean section the surgeon do external uterine massage and gentle traction on the exposed umbilical cord to facilitate placental delivery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood loss assessment after placental delivery
Time Frame: 12 hours
Determine estimated blood loss after placental delivery either by cord traction or manually during caesarean section through comparing pre and postoperative hemoglobin and haematocrit measurements
12 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Placental delivery time.
Time Frame: 30 minutes
time needed to deliver the placenta calculated from time of full baby delivery to the time of full placental delivery
30 minutes
Duration of operation
Time Frame: 2 hours
time calculated from first skin incision to the time of last stitch
2 hours
Need to use ecbolics
Time Frame: 30 minutes
documentation of the type, the dose of different ecbolics needed to stop any possible bleeding
30 minutes
Need of blood transfusion
Time Frame: 12 hours
documentation of the need and the amount needed of packed red blood cells packs or any other blood products if patient general condition required
12 hours
Blood loss > 1000 ml
Time Frame: 12 hours
counting down the cases of estimated blood loss more than 1000ml
12 hours
postoperative endometritis and puerperal pyrexia
Time Frame: one week
counting down the cases of puerperal pyrexia after exclusion of all other etiologies rather than endometritis
one week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

March 18, 2015

First Submitted That Met QC Criteria

March 28, 2015

First Posted (Estimate)

April 1, 2015

Study Record Updates

Last Update Posted (Actual)

May 30, 2017

Last Update Submitted That Met QC Criteria

May 24, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • afhsr-1-3-2015

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complications; Cesarean Section

Clinical Trials on manual removal

3
Subscribe